Працювала в 7 компаніях 22 роки 5 місяців
FMCG, Фармацевтика, Медицина та Охорона здоров'я
Regulatory Lead Janssen
Johnson&Johnson / Джонсон & Джонсон
FMCG
6 років 7 місяців
07.2019 - до теперішнього часу
Preparation and execution optimal regulatory strategies aimed to deliver product approvals and life cycle management in accordance with the regulatory objectives of the regional business.
Develop effective relationships and effective liaison with local commercial organization, distributors and service providers.
Provide regulatory guidance and advice on local country regulatory environments;
Provide assessment of the impact of new and changing regulations/requirements in Ukraine.
Ensure compliance of regulatory activities with Country laws and company internal protocols and procedures.
Budget planning.
1 person is under my subordination.
Ass. Director Regulatory Head CIS
Shire Ukraine LLC
Фармацевтика
2 роки 10 місяців
09.2016 - 06.2019
Preparation and execution optimal regulatory strategies aimed to deliver product approvals and life cycle management in accordance with the regulatory objectives of the regional business.
Act as a leadership team member in brand planning and business cases approval process.
Develop effective relationships with local commercial organization, distributors and service providers in applicable 10 CIS countries.
Provide effective liaison with the regulatory agencies in the region directly, through distributors contacts and service providers.
Provide regulatory guidance and advice on local country regulatory environments;
Provide assessment of the impact of new and changing regulations/requirements in CIS countries.
Ensure compliance of regulatory activities in CIS countries consistent with Country laws and company internal protocols and procedures.
Budget planning. Sources allocation.
3 persons are under my subordination.
Regulatory Affairs Manager Ukraine and CIS
представительство AbbVie Biopharmaceuticals
Фармацевтика
2 роки 1 місяць
08.2014 - 08.2016
New Marketing Authorization approval procedures for original products in Ukraine and other 11 CIS countries (Belarus, Moldova, Armenia, Azerbaijan, Georgia, Kazakhstan, Kyrgyzstan, Turkmenistan, Uzbekistan, and Tajikistan).
Regulatory strategy development for line extension of existing products portfolio. CMC and Labeling variations management for life-cycle of the products. Renewal procedures management. GMP recognition management. Quality and compliance management for RX products life-cycle.
Regulatory support in promotional materials development for new products and existing portfolio. Regulatory planning and monthly reports preparation.
Participate in meetings of EBA, AIPM, ACC and meetings with SEC about issue of harmonization of Legislation of Regulation Affairs between legislation in UA and EU countries for MP, FS, C according to EU Directives/Regulations/Guidelines.
2 persons were under my subordination.
Regulatory Affairs Manager
Bayer Ltd. / Байер, ООО
Фармацевтика
3 роки 3 місяці
05.2011 - 07.2014
New registrations, Renewals and variations to approved registration dossiers for Medicinal Products (MP), Food Supplements (FS) and Cosmetics (C).
Establish and maintain contacts with regulatory bodies, registrations agencies, expertise institutions and opinion leaders in the field of registration by open and transparent manner. Negotiate and communicate with HA all issues related to regulatory procedures. Ensure that all local procedures comply with global directives and procedure, as described in the procedure on review and implementation of global directives.
Coordinate registration issues as well as labelling compliance in local country proactively.
Contact HA on drug safety matters: PV, PSURs submission
Obtain approvals in line with registration plan.
Timely implementation of approved labeling and CMC changes into the packaging materials according to SOP and the local requirements. Provide change management: dossier timely, in good quality and properly documented submission and approval of variations.
Relevant regulatory processes by SOPs updating.
Monitoring of the local legislation and competitive environment changes, promoting awareness of regulatory requirements and registration status changes within the company, influencing legal landscape via local networking.
Contributing to the development of strategies that meet both regulatory and commercial objectives, contributing to the successful products' launches.
Participate in meetings of EBA, AIPM, ACC and meetings with SEC about issue of harmonization of Legislation of Regulation Affairs between legislation in UA and EU countries for MP, FS, C according to EU Directives/Regulations/Guidelines.
Manage of RA Specialist for different status products and type of procedures.
Regulatory Affairs Specialist
Maxima Health Research
Фармацевтика
1 рік
06.2010 - 05.2011
New registrations, Renewals and variations to approved registration dossiers for Medicinal Products (MP), Food Supplements (FS) and Cosmetics (C).
Establish and maintain contacts with regulatory bodies, registrations agencies, expertise institutions and opinion leaders in the field of registration by open and transparent manner.
Negotiate and communicate with HA all issues related to regulatory procedures.
Coordinate registration process for different companies (Pfizer, Gilead, Amgen, BMS, Mentholatum).
Junior research scientist
Institute of Experimental Pathology, Oncology and Radiobiology, National Academy of Sciences of Ukraine
Медицина та Охорона здоров'я
3 роки 4 місяці
02.2007 - 05.2010
Designing and carrying out the experiments to study DNA damage in normal and tumor cells using DNA Comet Assay after influence of nitric oxides and low doses of ionization radiation, using statistical programs for data analysis.
Preparation of scientific reports and publications, presentation of data on regular seminars and scientific meetings.
Laboratory assistant
Research Industrial Company “DiaProf Med”
Медицина та Охорона здоров'я
3 роки 6 місяців
09.2003 - 02.2007
Biotechnological outgoing quality control of Medical devices such as ELISA and PCR kits.
Recombinant protein construction and purification by chromatography.
Ключова інформація
- EU, USA and CIS legislation
- registration of pharmaceutical, immunobiological products and food supplements
- Brand planing
- strategy development
- SOP development
- recombinant protein construction and purification by chromatography
- quality control of PCR and ELISA kits for viruses detection
- the clinical diagnostics of infectious diseases by Real-Time PCR
- investigation of genotoxic effects and estimation of the level of DNA damage by the DNA Comet Assay
Навчалась в 2 закладах
Business school MIM- Kiev
MBA
Киев, 2015
T. Shevchenko National University
Biological Department, Diploma in Molecular Biology and Biochemistry
Киев, 2005
Володіє мовами
Англійська
вільно
Може проходити співбесіду на цій мові
Може проходити співбесіду на цій мові
Французька
базовий
Російська
рідна
Може проходити співбесіду на цій мові
Може проходити співбесіду на цій мові
Українська
рідна
Може проходити співбесіду на цій мові
Може проходити співбесіду на цій мові
Курси, тренінги, сертифікати
New regulation regarding EAEU
CIS Pharmaceutical Forum, Moscow, Russia
EU and emerging markets regulation
Global Pharmaceutical Regulatory Affairs Summit, Prague, Czech Republic
Intensive training in Strategy and Leadership in frames of MBA program
Tepper business school of Carnegie Mellon University, Pittsburgh, PA, USA
New regulation regarding EU integration
Ukrainian Pharmaceutical Forum
Intensive training in Regulatory Affairs of food supplement
Intensive training in Regulatory Affairs of pharmaceutical and immunobiological products
Intensive training in Standardization, certification and sanitary-epidemiological examination of food products
Annual school in Radiobiology for young scientists
Institute of Radiobiology, Obninsk, Russia
Intensive training course in Microarray Technology
Kocaeli University, Izmit, Turkey
English language intensive training course
Supported by the CRDF, Vodu-lui Vode, Moldova
Додаткова інформація
Научная деятельность
Publications
Yu. O. Kobozev, J. Sorochinska et. al. (2006) Optimization of cultivation conditions of recombinant E. coli strain KPR-42- producer human ?-interferon. Mikrobiologichny Zhurnal (Journal of Microbilogy, in Ukrainian) 68, p. 41-47
J. Sorochinska, V. Mikhailenko. (2008). Application of the comet assay for the DNA damage assessment caused by different environmental agents. Oncology 10(3), p. 303-309
V. Mikhailenko, L. Ieleiko, A.Glavin, J. Sorochinska. (2008). Biomarkers of nanoparticles impact on biological systems. Nanomaterials: Risks and Benefits. NATO Science for Peace and Security Series 2008; ISBN:978-1-4020-9490-3, p. 67-82
V. Mikhailenko, L.Ieleiko, A.Glavin, J.Sorochinska. (2008). Risk assessment of nanoparticles impact on organism based on biological markers system. Proceedings of the Society for Risk Analysis Annual Meeting,. Boston, p.19
V.Mikhailenko, L.Ieleiko, A.Glavin, J. Sorochinska. (2009). Carbon Nanoparticles Impact on Energy Metabolism, Genotoxicity and Free Radicals Level. Handbook of Free Radicals: Formation, Types and Effects 2009; ISBN: 978-1-60876-101-2, p.133-137
Patent № 50133 "Method of reducing radiation load on the organizm"
Водительское удостоверение
A, B1,B
Ульяна
Ульяна
Head of regulatory affairs

Київ
Працює, але відкритий для пропозицій
повна зайнятість
Оновлено 1 день тому